Therapy of Helicobacter pylori: Current status and issues

Gastroenterology

Volumn 118, Issue 2 SUPPL., 2000, Pages

  Graham, David Y ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE;

ANTIBIOTIC RESISTANCE; DRUG POTENTIATION; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0033965556     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0016-5085(00)70003-5     Document Type: Article

References (51)

1. EG Clark N. Danbolt The Oslo study of the natural course of untreated syphilis. An epidemiologic investigation based on re-study of the Boeck-Burrsgaard material Med Clin North Am 48 1964 613 623
2. DY. Graham Can therapy ever be denied for Helicobacter pylori infection? Gastroenterology 113 1997 S113 S117
3. DY. Graham Evolution of concepts regarding Helicobacter pylori : from a cause of gastritis to a public health problem Am J Gastroenterol 89 1994 469 472
4. National Cancer Institute Seer cancer statistics review , 1973–1992: tables and graphs 1995 NIH Bethesda, MD Pub. No. 96–2789
5. DY. Graham Helicobacter pylori infection in the pathogenesis of duodenal ulcer and gastric cancer: a model Gastroenterology 113 1997 1983 1991
6. SJ Zanten M Bradette A Farley D Leddin T Lind P Unge E Bayerdorffer RC Spiller C O’Morain P Sipponen M Wrangstadh L Zeijlon P. Sinclair The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy Aliment Pharmacol Ther 13 1999 289 295
7. T Lind F Megraud P Unge E Bayerdorffer C O’Morain R Spiller S Veldhuyzen van Zanten KD Bardhan M Hellblom M Wrangstadh L Zeijlon C. Cederberg The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies Gastroenterology 116 1999 248 253
8. P Malfertheiner E Bayerdorffer U Diete J Gil T Lind P Misiuna C O’Morain P Sipponen RC Spiller J Stasiewicz H Treichel L Ujszaszy P Unge SJ Zanten L. Zeijlon The GU-MACH study: the effect of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer Aliment Pharmacol Ther 13 1999 703 712
9. T Lind S Veldhuyzen van Zanten P Unge R Spiller E Bayerdorffer C O’Morain KD Bardhan M Bradette N Chiba M Wrangstadh C Cederberg JP. Idstrom Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study Helicobacter 1 1996 138 144
10. J Huang RH. Hunt The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole Aliment Pharmacol Ther 13 1999 719 729
11. F Catalano G Branciforte R Catanzaro C Bentivegna R Cipolla G Nuciforo A. Brogna Comparative treatment of Helicobacter pylori -positive duodenal ulcer using pantoprazole at low and high doses versus omeprazole in triple therapy Helicobacter 4 1999 178 184
12. HG Dammann UR Folsch EG Hahn HU Klor T Kirchner M. Kist 7 vs 14 day treatment with pantoprazole, clarithromycin and metronidazole for cure of H. pylori infection in duodenal ulcer patients Gut 41 1998 A95 (abstr)
13. M Katicic V Presecki M Marusic M Prskalo M Ticak B Sabaric M Dominis S Kalenic S Dzebro V Colic-Cvrlje B Papa S Naumovsk-Mihalic V. Plecko Eradication of H . pylori with two triple-therapy regimens of 7, 10 and 14 days duration Gut 41 1998 A100 (abstr)
14. H Lamouliatte S Forestier F. Perie Lansoprazole (Lanso) 30 mg or 60 mg combined with two antibiotics [amoxicillin (Amox) and clarithromycin (Clari)] to eradicate Helicobacter pylori (Hpylori) Gastroenterology 114 1998 A194 (abstr)
15. KD Bardhan E Bayerdörffer J Delchier M Hellblom F Megraud A Stubberod SJ Veldhuyzen van Zanten T Lind C Burman P. Gromark H. pylori (Hp) eradication with omeprazole (O), metronidazole (M) and amoxicillin (A): the impact of drug dosing & resistance on efficacy —the Homer story Gastroenterology 114 1998 A65 (abstr)
16. MHG Houben HWS Koops EAJ Rauws BW van ’t Hoff AV Ende FJ Kate GNJ. Tytgat Efficacy of PPI-triple therapy in H. pylori (HP) positive patients with peptic ulcer versus patients with functional dyspepsia Gastroenterology 116 1999 A190 (abstr)
17. N Broutet A Marais H Lamouliatte R Samoyeau F. Megraud Cag negative status: a risk factor for failure of Helicobacter pylori triple therapies in non-ulcer dyspepsia Gut 43 1998 A79 (abstr)
18. V Savarino M Neri S. Vigneri PPI-based triple therapy in eradication of H . pylori infection Gastroenterology 117 1999 746 (letter)
19. EJ Kuipers EC. Klinkenberg-Knol Helicobacter pylori , acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion Gastroenterology 116 1999 479 483
20. MB Fennerty TO Kovacs R Krause M Haber A Weissfeld N Siepman P. Rose A comparison of 10 and 14 days of lansoprazole triple therapy for eradication of Helicobacter pylori Arch Intern Med 158 1998 1651 1656
21. DY. Graham Antibiotic resistance in Helicobacter pylori : implications for therapy Gastroenterology 115 1998 1272 1277
22. T Breuer DY. Graham Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective? Am J Gastroenterol 94 1999 725 729
23. DY Graham J Hoffman HM el-Zimaity DP Graham M. Osato Twice a day quadruple therapy (bismuth subsalicylate, tetracycline, metronidazole plus lansoprazole) for treatment of Helicobacter pylori infection Aliment Pharmacol Ther 11 1997 935 938
24. M Gschwantler B Dragosics K Schutze H Wurzer AM Hirschl E Pasching M Wimmer M Klimpfinger G Oberhuber G Brandstatter E Hentschel W. Weiss Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori— a randomized, controlled trial Aliment Pharmacol Ther 13 1999 1063 1069
25. JM Gotz RA Veenendaal M Veselic S Bernards CB. Lamers Triple therapy with ranitidine, clarithromycin, and metronidazole in the treatment of Helicobacter pylori Scand J Gastroenterol Suppl 212 1995 34 37
26. T Breuer JG Kim HM el-Zimaity S Nikajima H Ota M Osato DY. Graham Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in Korea Aliment Pharmacol Ther 11 1997 939 942
27. KL Goh N Parasakthi SY Chuah M. Toetsch Combination amoxycillin and metronidazole with famotidine in the eradication of Helicobacter pylori— a randomized, double-blind comparison of a three times daily and twice daily regimen Eur J Gastroenterol Hepatol 9 1997 1091 1095
28. A. Harris Ranitidine in a twice daily triple therapy regimen for the eradication of Helicobacter pylori Eur J Gastroenterol Hepatol 9 1997 544 (letter)
29. MM Yousfi HM el-Zimaity RA Cole RM Genta DY. Graham Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli’s triple therapy) Aliment Pharmacol Ther 10 1996 119 122
30. MT Al-Assi RM Genta DY. Graham Short report: omeprazole-tetracycline combinations are inadequate as therapy for Helicobacter pylori infection Aliment Pharmacol Ther 8 1994 259 262
31. DY Graham GM Lew FC Ramirez RM Genta PD Klein HM. Malaty A nonmetronidazole triple therapy for eradication of Helicobacter pylori infection—tetracycline, amoxicillin, bismuth Aliment Pharmacol Ther 7 1993 111 113
32. MH Houben DV Beek EF Hensen AJ Craen EA Rauws GN. Tytgat A systematic review of Helicobacter pylori eradication therapy—the impact of antimicrobial resistance on eradication rates Aliment Pharmacol Ther 13 1999 1047 1055
33. EJ van der Wouden JC Thijs AA van Zwet WJ Sluiter JH. Kleibeuker The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti- Helicobacter pylori regimens: a meta-analysis Am J Gastroenterol 94 1999 1751 1759
34. DY Graham WA de Boer GN. Tytgat Choosing the best anti- Helicobacter pylori therapy: effect of antimicrobial resistance Am J Gastroenterol 91 1996 1072 1076
35. Dore MP, Leandro G, Realdi G, Sepulveda A, Graham DY. The effect of pre-treatment antibiotic resistance to metronidazole or clarithromycin on the outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci (in press).
36. T. Fagan Exact 95% confidence intervals for differences in binomial proportions Comput Biol Med 29 1999 83 87
37. T. Fagan Quickbasic program for exact and mid-P confidence intervals for a binomial proportion Comput Biol Med 26 1996 263 267
38. N Chiba BV Rao JW Rademaker RH. Hunt Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori Am J Gastroenterol 87 1992 1716 1727
39. F Bazzoli P Pozzato M Zagari S Fossi L Ricciardiello G Nicolini D Berretti L. De Luca Efficacy of lansoprazole in eradicating Helicobacter pylori : a meta-analysis Helicobacter 3 1998 195 201
40. RJ Laheij LG Rossum JB Jansen H Straatman AL. Verbeek Evaluation of treatment regimens to cure Helicobacter pylori infection—a meta-analysis Aliment Pharmacol Ther 13 1999 857 864
41. CH Schmid G Whiting D Cory SD Ross TC. Chalmers Omeprazole plus antibiotics in the eradication of Helicobacter pylori infection: a meta-regression analysis of randomized, controlled trials Am J Ther 6 1999 25 36
42. G Holtmann P Layer H. Goebell Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication—a meta-analysis Lancet 347 1996 763 (letter)
43. R Lamberts W Creutzfeldt HG Struber G Brunner E. Solcia Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis Gastroenterology 104 1993 1356 1370
44. EJ Kuipers L Lundell EC Klinkenberg-Knol N Havu HP Festen B Liedman CB Lamers JB Jansen J Dalenback P Snel GF Nelis SG. Meuwissen Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication N Engl J Med 334 1996 1018 1022
45. A Meining G Kiel M. Stolte Changes in Helicobacter pylori -induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease Aliment Pharmacol Ther 12 1998 735 740
46. M Stolte B. Bethke Elimination of Helicobacter pylori under treatment with omeprazole Z Gastroenterol 28 1990 271 274
47. EC Klinkenberg-Knol HP Festen JB Jansen CB Lamers F Nelis P Snel A Luckers CP Dekkers N Havu SG. Meuwissen Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety Ann Intern Med 121 1994 161 167
48. 2-receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients Aliment Pharmacol Ther 11 1997 729 734
49. DY. Graham Helicobacter pylori , GERD, NSAIDs, and cancer: where we really stand Am J Gastroenterol 94 1999 1420 1421 (letter)
50. DY Graham Y. Yamaoka H . pylori and cagA: relationships with gastric cancer, duodenal ulcer, and reflux esophagitis and its complications Helicobacter 3 1998 145 151
51. BS Anand DY. Graham Ulcer and gastritis Endoscopy 31 1999 215 225